EUVIMEDEUVIMED entdecken
Crossref

Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment

Zejing Gao, Yi Wei, Jia Ge, Jingxuan Liu, Ying Qin, Fangling Gong, Guanghui Ma iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c04010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Zejing Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China. Hauptthemen laut MEDLINE: Liraglutide, Microspheres, Diabetes Mellitus, Type 2, Delayed-Action Preparations. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideMicrospheresDiabetes Mellitus, Type 2Delayed-Action PreparationsAnimalsHypoglycemic AgentsMiceBlood GlucoseDiabetes Mellitus, ExperimentalMaleDrug LiberationEmulsionsParticle Size

Stichwörter der Autor:innen

amphiphilic structurein vitro and in vivo degradationliraglutidesustained-release microspherestype 2 diabetes mellitus

Substanzen

LiraglutideDelayed-Action PreparationsHypoglycemic AgentsBlood GlucoseEmulsions

Autor:innen und Institutionen

  • State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China.
  • Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, P. R. China.
  • University of the Chinese Academy of Sciences, Beijing 100049, P. R. China.

ORCID-Profile: Guanghui Ma

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Gao, Z., Wei, Y., Ge, J., Liu, J., Qin, Y., Gong, F., & Ma, G. (2024). Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c04010

Vancouver

Gao Z, Wei Y, Ge J, Liu J, Qin Y, Gong F, et al. Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c04010

BibTeX
@article{Gao2024,
  author = {Gao, Zejing and Wei, Yi and Ge, Jia and Liu, Jingxuan and Qin, Ying and Gong, Fangling and Ma, Guanghui},
  title = {Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c04010}
}
Kostenlos starten →